(Q46857189)

25 December 2017

title

Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function (English)

1 reference

25 December 2017

1 reference

Gary E Duncan

1

1 reference

25 December 2017

Sheryl S Moy

series ordinal

2

1 reference

25 December 2017

Jeffery A Lieberman

series ordinal

3

1 reference

25 December 2017

Beverly H Koller

series ordinal

4

1 reference

25 December 2017

publication date

16 December 2005

1 reference

25 December 2017

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

25 December 2017

volume

184

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

190-200

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-0214-1

exact match

0 references

cites work

Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0214-1

Amelioration of negative symptoms in schizophrenia by glycine.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0214-1

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0214-1

The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

21 January 2018

1 reference

12 December 2020

Intra- and interstrain differences in models of "behavioral despair".

1 reference

12 December 2020

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

12 December 2020

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

12 December 2020

Inbred strain differences in prepulse inhibition of the mouse startle response

1 reference

12 December 2020

Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone

1 reference

12 December 2020

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

12 December 2020

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

12 December 2020

Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats

1 reference

12 December 2020

Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

1 reference

12 December 2020

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

12 December 2020

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

12 December 2020

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

1 reference

12 December 2020

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential

1 reference

12 December 2020

Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine

1 reference

12 December 2020

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

1 reference

12 December 2020

Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro.

1 reference

12 December 2020

Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function

1 reference

12 December 2020

Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition

1 reference

12 December 2020

Seroquel restores sensorimotor gating in phencyclidine-treated rats.

1 reference

12 December 2020

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1 reference

12 December 2020

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

12 December 2020

Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice

1 reference

12 December 2020

Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.

1 reference

12 December 2020

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

1 reference

12 December 2020

Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia

1 reference

12 December 2020

Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.

1 reference

12 December 2020

Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.

1 reference

12 December 2020

Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice

1 reference

12 December 2020

Effects of ketamine in normal and schizophrenic volunteers

1 reference

12 December 2020

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

12 December 2020

D-serine added to antipsychotics for the treatment of schizophrenia

1 reference

12 December 2020

Disruption of prepulse inhibition in mice lacking mGluR1.

1 reference

12 December 2020

Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function

1 reference

12 December 2020

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.

1 reference

12 December 2020

Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit

1 reference

12 December 2020

Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.

1 reference

12 December 2020

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

1 reference

12 December 2020

Antidepressant-like effects in various mice strains in the forced swimming test.

1 reference

12 December 2020

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

12 December 2020

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

12 December 2020

Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.

1 reference

12 December 2020

Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia

1 reference

12 December 2020

Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle

1 reference

12 December 2020

Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice

1 reference

12 December 2020

10.1007/S00213-005-0214-1

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16362405

1 reference

25 December 2017